Savolitinib + osimertinib treatment in China: consultation records checklist

1. Bring the original pathology and complete EGFR report to establish the initial subtype.
2. Submit the complete post-resistance MET report, including method, threshold, sample type and collection date.
3. List all targeted medicines, dose adjustments, treatment durations and progression records chronologically to support a full resistance assessment.
4. Prepare the two most recent imaging studies and information on progression sites, plus comorbidities and previous adverse effects.
5. Before departure, confirm the hospital assessment, any additional tests, and itemised medical and coordination service budgets. Then arrange flights, accommodation, interpreting, follow-up after returning home, medication supply and emergency contacts. You do not need to arrange new tests yourself for an initial consultation.

Questions to clarify
- Do I meet the eligibility criteria?
- What are the separate medical and coordination service costs without Chinese health insurance or free-drug assistance?
- How are initial treatment, ongoing treatment, return travel and follow-up arranged?
- Which risks require immediate contact with the hospital?

An initial service consultation does not replace medical assessment.